nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CYP3A4—Thiotepa—sarcoma	0.0734	0.275	CbGbCtD
Nimodipine—CACNA1S—pes—sarcoma	0.0668	0.259	CbGeAlD
Nimodipine—CYP3A5—Vincristine—sarcoma	0.0557	0.209	CbGbCtD
Nimodipine—CYP3A5—Etoposide—sarcoma	0.051	0.191	CbGbCtD
Nimodipine—CYP3A4—Mitoxantrone—sarcoma	0.0316	0.118	CbGbCtD
Nimodipine—CYP3A4—Vincristine—sarcoma	0.0217	0.0814	CbGbCtD
Nimodipine—CYP3A4—Etoposide—sarcoma	0.0199	0.0746	CbGbCtD
Nimodipine—CYP3A4—Doxorubicin—sarcoma	0.0136	0.0509	CbGbCtD
Nimodipine—CACNB3—mammary gland—sarcoma	0.0113	0.044	CbGeAlD
Nimodipine—CACNA1S—seminal vesicle—sarcoma	0.00813	0.0315	CbGeAlD
Nimodipine—CACNB3—myometrium—sarcoma	0.00805	0.0312	CbGeAlD
Nimodipine—CACNB3—seminal vesicle—sarcoma	0.00727	0.0282	CbGeAlD
Nimodipine—CACNB4—tendon—sarcoma	0.00597	0.0232	CbGeAlD
Nimodipine—AHR—myometrium—sarcoma	0.00596	0.0231	CbGeAlD
Nimodipine—Platelet count decreased—Mitoxantrone—sarcoma	0.00595	0.0229	CcSEcCtD
Nimodipine—Ileus—Thiotepa—sarcoma	0.00579	0.0223	CcSEcCtD
Nimodipine—AHR—seminal vesicle—sarcoma	0.00539	0.0209	CbGeAlD
Nimodipine—CACNB3—uterus—sarcoma	0.00522	0.0202	CbGeAlD
Nimodipine—Ileus—Vincristine—sarcoma	0.00514	0.0197	CcSEcCtD
Nimodipine—CACNA1S—tendon—sarcoma	0.00512	0.0198	CbGeAlD
Nimodipine—CACNB4—testis—sarcoma	0.00495	0.0192	CbGeAlD
Nimodipine—CACNB1—tendon—sarcoma	0.00477	0.0185	CbGeAlD
Nimodipine—CACNB3—tendon—sarcoma	0.00458	0.0177	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—sarcoma	0.00451	0.0175	CbGeAlD
Nimodipine—CACNA1C—myometrium—sarcoma	0.00436	0.0169	CbGeAlD
Nimodipine—NR3C2—myometrium—sarcoma	0.00397	0.0154	CbGeAlD
Nimodipine—CACNB1—testis—sarcoma	0.00395	0.0153	CbGeAlD
Nimodipine—Fluid retention—Thiotepa—sarcoma	0.00389	0.015	CcSEcCtD
Nimodipine—AHR—cardiac atrium—sarcoma	0.00389	0.0151	CbGeAlD
Nimodipine—AHR—uterus—sarcoma	0.00387	0.015	CbGeAlD
Nimodipine—CACNB3—testis—sarcoma	0.00379	0.0147	CbGeAlD
Nimodipine—CACNA1C—connective tissue—sarcoma	0.00361	0.014	CbGeAlD
Nimodipine—NR3C2—seminal vesicle—sarcoma	0.00359	0.0139	CbGeAlD
Nimodipine—CACNB2—cardiac atrium—sarcoma	0.00353	0.0137	CbGeAlD
Nimodipine—Phlebitis—Dactinomycin—sarcoma	0.00343	0.0132	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Thiotepa—sarcoma	0.00342	0.0131	CcSEcCtD
Nimodipine—NR3C2—hematopoietic system—sarcoma	0.00341	0.0132	CbGeAlD
Nimodipine—AHR—tendon—sarcoma	0.00339	0.0131	CbGeAlD
Nimodipine—CACNA1C—smooth muscle tissue—sarcoma	0.0033	0.0128	CbGeAlD
Nimodipine—NR3C2—connective tissue—sarcoma	0.00328	0.0127	CbGeAlD
Nimodipine—AHR—bone marrow—sarcoma	0.00328	0.0127	CbGeAlD
Nimodipine—Lactic dehydrogenase activity increased—Epirubicin—sarcoma	0.00323	0.0124	CcSEcCtD
Nimodipine—CACNA1D—cardiac atrium—sarcoma	0.00308	0.0119	CbGeAlD
Nimodipine—CACNB2—tendon—sarcoma	0.00307	0.0119	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—sarcoma	0.003	0.0116	CbGeAlD
Nimodipine—Lactic dehydrogenase activity increased—Doxorubicin—sarcoma	0.00299	0.0115	CcSEcCtD
Nimodipine—Phlebitis—Mitoxantrone—sarcoma	0.00298	0.0115	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Etoposide—sarcoma	0.00295	0.0113	CcSEcCtD
Nimodipine—CACNB1—lymph node—sarcoma	0.00286	0.0111	CbGeAlD
Nimodipine—CACNA1C—cardiac atrium—sarcoma	0.00285	0.011	CbGeAlD
Nimodipine—Blood lactate dehydrogenase increased—Epirubicin—sarcoma	0.00284	0.0109	CcSEcCtD
Nimodipine—Cardiac failure congestive—Mitoxantrone—sarcoma	0.00283	0.0109	CcSEcCtD
Nimodipine—AHR—testis—sarcoma	0.00281	0.0109	CbGeAlD
Nimodipine—CACNB3—lymph node—sarcoma	0.00275	0.0106	CbGeAlD
Nimodipine—Liver function test abnormal—Dactinomycin—sarcoma	0.00273	0.0105	CcSEcCtD
Nimodipine—AHR—liver—sarcoma	0.00265	0.0103	CbGeAlD
Nimodipine—Hyponatraemia—Vincristine—sarcoma	0.00265	0.0102	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Doxorubicin—sarcoma	0.00263	0.0101	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00263	0.0101	CcSEcCtD
Nimodipine—NR3C2—cardiac atrium—sarcoma	0.00259	0.01	CbGeAlD
Nimodipine—Hyponatraemia—Mitoxantrone—sarcoma	0.00258	0.00992	CcSEcCtD
Nimodipine—NR3C2—uterus—sarcoma	0.00258	0.00999	CbGeAlD
Nimodipine—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00257	0.00988	CcSEcCtD
Nimodipine—CACNB2—testis—sarcoma	0.00255	0.00987	CbGeAlD
Nimodipine—Phlebitis—Etoposide—sarcoma	0.00248	0.00954	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Etoposide—sarcoma	0.00246	0.00945	CcSEcCtD
Nimodipine—CACNB2—liver—sarcoma	0.00241	0.00933	CbGeAlD
Nimodipine—Cardiac failure congestive—Etoposide—sarcoma	0.00236	0.00906	CcSEcCtD
Nimodipine—Ileus—Epirubicin—sarcoma	0.00233	0.00896	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00227	0.00871	CcSEcCtD
Nimodipine—NR3C2—tendon—sarcoma	0.00226	0.00875	CbGeAlD
Nimodipine—Jaundice—Thiotepa—sarcoma	0.00224	0.00859	CcSEcCtD
Nimodipine—CACNA1D—testis—sarcoma	0.00222	0.00862	CbGeAlD
Nimodipine—Hepatobiliary disease—Thiotepa—sarcoma	0.00217	0.00834	CcSEcCtD
Nimodipine—Sweating increased—Mitoxantrone—sarcoma	0.00216	0.00832	CcSEcCtD
Nimodipine—Ileus—Doxorubicin—sarcoma	0.00216	0.00829	CcSEcCtD
Nimodipine—CACNA1D—liver—sarcoma	0.0021	0.00815	CbGeAlD
Nimodipine—CACNA1C—testis—sarcoma	0.00205	0.00796	CbGeAlD
Nimodipine—Hepatitis—Dactinomycin—sarcoma	0.00204	0.00785	CcSEcCtD
Nimodipine—AHR—lymph node—sarcoma	0.00203	0.00788	CbGeAlD
Nimodipine—Depression—Vincristine—sarcoma	0.00203	0.00779	CcSEcCtD
Nimodipine—Jaundice—Mitoxantrone—sarcoma	0.00193	0.00742	CcSEcCtD
Nimodipine—Cramp muscle—Etoposide—sarcoma	0.00193	0.0074	CcSEcCtD
Nimodipine—Cardiac disorder—Thiotepa—sarcoma	0.00191	0.00734	CcSEcCtD
Nimodipine—Flushing—Dactinomycin—sarcoma	0.0019	0.00729	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Etoposide—sarcoma	0.00189	0.00725	CcSEcCtD
Nimodipine—NR3C2—testis—sarcoma	0.00187	0.00725	CbGeAlD
Nimodipine—Angiopathy—Thiotepa—sarcoma	0.00187	0.00718	CcSEcCtD
Nimodipine—Immune system disorder—Thiotepa—sarcoma	0.00186	0.00715	CcSEcCtD
Nimodipine—CACNB2—lymph node—sarcoma	0.00185	0.00715	CbGeAlD
Nimodipine—CYP3A5—hematopoietic system—sarcoma	0.00184	0.00715	CbGeAlD
Nimodipine—Bradycardia—Mitoxantrone—sarcoma	0.00181	0.00696	CcSEcCtD
Nimodipine—Sweating increased—Etoposide—sarcoma	0.0018	0.00692	CcSEcCtD
Nimodipine—Hepatitis—Mitoxantrone—sarcoma	0.00178	0.00683	CcSEcCtD
Nimodipine—NR3C2—liver—sarcoma	0.00177	0.00685	CbGeAlD
Nimodipine—Cardiac disorder—Vincristine—sarcoma	0.00169	0.00651	CcSEcCtD
Nimodipine—Anaemia—Thiotepa—sarcoma	0.00166	0.00637	CcSEcCtD
Nimodipine—Angiopathy—Vincristine—sarcoma	0.00166	0.00637	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Epirubicin—sarcoma	0.00165	0.00634	CcSEcCtD
Nimodipine—Anaemia—Dactinomycin—sarcoma	0.00164	0.00632	CcSEcCtD
Nimodipine—CACNA1D—lymph node—sarcoma	0.00161	0.00625	CbGeAlD
Nimodipine—Jaundice—Etoposide—sarcoma	0.00161	0.00617	CcSEcCtD
Nimodipine—Fluid retention—Epirubicin—sarcoma	0.00157	0.00602	CcSEcCtD
Nimodipine—Hepatobiliary disease—Etoposide—sarcoma	0.00156	0.00599	CcSEcCtD
Nimodipine—Hypertension—Thiotepa—sarcoma	0.00155	0.00595	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—sarcoma	0.00153	0.00587	CcSEcCtD
Nimodipine—Myalgia—Thiotepa—sarcoma	0.00153	0.00586	CcSEcCtD
Nimodipine—Myalgia—Dactinomycin—sarcoma	0.00151	0.00582	CcSEcCtD
Nimodipine—CACNA1C—lymph node—sarcoma	0.00149	0.00577	CbGeAlD
Nimodipine—Anaemia—Vincristine—sarcoma	0.00147	0.00565	CcSEcCtD
Nimodipine—Oedema—Dactinomycin—sarcoma	0.00145	0.00558	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—sarcoma	0.00145	0.00557	CcSEcCtD
Nimodipine—Nervous system disorder—Thiotepa—sarcoma	0.00143	0.00551	CcSEcCtD
Nimodipine—Thrombocytopenia—Thiotepa—sarcoma	0.00143	0.0055	CcSEcCtD
Nimodipine—Anaemia—Mitoxantrone—sarcoma	0.00143	0.0055	CcSEcCtD
Nimodipine—Tachycardia—Thiotepa—sarcoma	0.00143	0.00549	CcSEcCtD
Nimodipine—Thrombocytopenia—Dactinomycin—sarcoma	0.00142	0.00546	CcSEcCtD
Nimodipine—Phlebitis—Epirubicin—sarcoma	0.00139	0.00535	CcSEcCtD
Nimodipine—CYP3A4—hematopoietic system—sarcoma	0.00138	0.00536	CbGeAlD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—sarcoma	0.00138	0.00529	CcSEcCtD
Nimodipine—Cardiac disorder—Etoposide—sarcoma	0.00137	0.00527	CcSEcCtD
Nimodipine—Flushing—Etoposide—sarcoma	0.00137	0.00527	CcSEcCtD
Nimodipine—Hypertension—Vincristine—sarcoma	0.00137	0.00527	CcSEcCtD
Nimodipine—NR3C2—lymph node—sarcoma	0.00136	0.00525	CbGeAlD
Nimodipine—Myalgia—Vincristine—sarcoma	0.00135	0.0052	CcSEcCtD
Nimodipine—Angiopathy—Etoposide—sarcoma	0.00134	0.00516	CcSEcCtD
Nimodipine—Hypertension—Mitoxantrone—sarcoma	0.00134	0.00514	CcSEcCtD
Nimodipine—Immune system disorder—Etoposide—sarcoma	0.00134	0.00513	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00133	0.00512	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00132	0.00508	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—sarcoma	0.00132	0.00508	CcSEcCtD
Nimodipine—Myalgia—Mitoxantrone—sarcoma	0.00132	0.00506	CcSEcCtD
Nimodipine—Oedema—Vincristine—sarcoma	0.0013	0.00498	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—sarcoma	0.00129	0.00495	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00127	0.0049	CcSEcCtD
Nimodipine—Nervous system disorder—Vincristine—sarcoma	0.00127	0.00489	CcSEcCtD
Nimodipine—Thrombocytopenia—Vincristine—sarcoma	0.00127	0.00488	CcSEcCtD
Nimodipine—Oedema—Mitoxantrone—sarcoma	0.00126	0.00485	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00126	0.00485	CcSEcCtD
Nimodipine—Hyperhidrosis—Vincristine—sarcoma	0.00125	0.00482	CcSEcCtD
Nimodipine—Muscle spasms—Etoposide—sarcoma	0.00124	0.00476	CcSEcCtD
Nimodipine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00124	0.00475	CcSEcCtD
Nimodipine—Tachycardia—Mitoxantrone—sarcoma	0.00123	0.00474	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—sarcoma	0.00122	0.0047	CcSEcCtD
Nimodipine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00122	0.00469	CcSEcCtD
Nimodipine—Hypotension—Vincristine—sarcoma	0.00121	0.00466	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—sarcoma	0.0012	0.00462	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.0012	0.00461	CcSEcCtD
Nimodipine—Anaemia—Etoposide—sarcoma	0.00119	0.00457	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00118	0.00454	CcSEcCtD
Nimodipine—Hypotension—Mitoxantrone—sarcoma	0.00118	0.00454	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00115	0.00442	CcSEcCtD
Nimodipine—Dyspnoea—Mitoxantrone—sarcoma	0.00113	0.00433	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Vincristine—sarcoma	0.00112	0.0043	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—sarcoma	0.00111	0.00428	CcSEcCtD
Nimodipine—Hypertension—Etoposide—sarcoma	0.00111	0.00427	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.00111	0.00426	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—sarcoma	0.00111	0.00425	CcSEcCtD
Nimodipine—Hypersensitivity—Thiotepa—sarcoma	0.00108	0.00414	CcSEcCtD
Nimodipine—Hypersensitivity—Dactinomycin—sarcoma	0.00107	0.00411	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00106	0.00406	CcSEcCtD
Nimodipine—Pruritus—Thiotepa—sarcoma	0.00103	0.00398	CcSEcCtD
Nimodipine—Thrombocytopenia—Etoposide—sarcoma	0.00103	0.00395	CcSEcCtD
Nimodipine—Tachycardia—Etoposide—sarcoma	0.00103	0.00394	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—sarcoma	0.00102	0.00393	CcSEcCtD
Nimodipine—Hyperhidrosis—Etoposide—sarcoma	0.00102	0.0039	CcSEcCtD
Nimodipine—Diarrhoea—Thiotepa—sarcoma	0.001	0.00385	CcSEcCtD
Nimodipine—Diarrhoea—Dactinomycin—sarcoma	0.000993	0.00382	CcSEcCtD
Nimodipine—Hypotension—Etoposide—sarcoma	0.000982	0.00377	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000978	0.00376	CcSEcCtD
Nimodipine—Dizziness—Thiotepa—sarcoma	0.000967	0.00372	CcSEcCtD
Nimodipine—Hypersensitivity—Vincristine—sarcoma	0.000956	0.00367	CcSEcCtD
Nimodipine—CYP3A5—liver—sarcoma	0.000955	0.0037	CbGeAlD
Nimodipine—Dyspnoea—Etoposide—sarcoma	0.000937	0.0036	CcSEcCtD
Nimodipine—Hypersensitivity—Mitoxantrone—sarcoma	0.000931	0.00358	CcSEcCtD
Nimodipine—Vomiting—Thiotepa—sarcoma	0.00093	0.00357	CcSEcCtD
Nimodipine—Vomiting—Dactinomycin—sarcoma	0.000923	0.00355	CcSEcCtD
Nimodipine—Rash—Thiotepa—sarcoma	0.000922	0.00354	CcSEcCtD
Nimodipine—Dermatitis—Thiotepa—sarcoma	0.000922	0.00354	CcSEcCtD
Nimodipine—Headache—Thiotepa—sarcoma	0.000916	0.00352	CcSEcCtD
Nimodipine—Rash—Dactinomycin—sarcoma	0.000915	0.00352	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Etoposide—sarcoma	0.000907	0.00349	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—sarcoma	0.0009	0.00346	CcSEcCtD
Nimodipine—Diarrhoea—Vincristine—sarcoma	0.000888	0.00341	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—sarcoma	0.000873	0.00336	CcSEcCtD
Nimodipine—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—sarcoma	0.000873	0.00406	CbGpPWpGaD
Nimodipine—Nausea—Thiotepa—sarcoma	0.000869	0.00334	CcSEcCtD
Nimodipine—Diarrhoea—Mitoxantrone—sarcoma	0.000864	0.00332	CcSEcCtD
Nimodipine—Nausea—Dactinomycin—sarcoma	0.000862	0.00331	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000861	0.00401	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000859	0.004	CbGpPWpGaD
Nimodipine—Dizziness—Vincristine—sarcoma	0.000858	0.0033	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000853	0.00397	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MYOG—sarcoma	0.00085	0.00395	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—SRC—sarcoma	0.000845	0.00393	CbGpPWpGaD
Nimodipine—Bradycardia—Epirubicin—sarcoma	0.000844	0.00324	CcSEcCtD
Nimodipine—CACNB3—NCAM signaling for neurite out-growth—HRAS—sarcoma	0.000834	0.00388	CbGpPWpGaD
Nimodipine—Jaundice—Doxorubicin—sarcoma	0.000833	0.0032	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—sarcoma	0.000829	0.00319	CcSEcCtD
Nimodipine—Vomiting—Vincristine—sarcoma	0.000825	0.00317	CcSEcCtD
Nimodipine—Rash—Vincristine—sarcoma	0.000818	0.00314	CcSEcCtD
Nimodipine—Dermatitis—Vincristine—sarcoma	0.000817	0.00314	CcSEcCtD
Nimodipine—Headache—Vincristine—sarcoma	0.000813	0.00312	CcSEcCtD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—NRAS—sarcoma	0.000813	0.00378	CbGpPWpGaD
Nimodipine—CACNB1—NCAM signaling for neurite out-growth—HRAS—sarcoma	0.000812	0.00378	CbGpPWpGaD
Nimodipine—Hepatobiliary disease—Doxorubicin—sarcoma	0.000808	0.00311	CcSEcCtD
Nimodipine—Vomiting—Mitoxantrone—sarcoma	0.000803	0.00309	CcSEcCtD
Nimodipine—CACNB4—Transmission across Chemical Synapses—MDM2—sarcoma	0.000802	0.00373	CbGpPWpGaD
Nimodipine—Rash—Mitoxantrone—sarcoma	0.000797	0.00306	CcSEcCtD
Nimodipine—Dermatitis—Mitoxantrone—sarcoma	0.000796	0.00306	CcSEcCtD
Nimodipine—Headache—Mitoxantrone—sarcoma	0.000791	0.00304	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—sarcoma	0.000781	0.003	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—CREB1—sarcoma	0.000775	0.00361	CbGpPWpGaD
Nimodipine—Hypersensitivity—Etoposide—sarcoma	0.000774	0.00297	CcSEcCtD
Nimodipine—CACNB2—Developmental Biology—EZR—sarcoma	0.000774	0.0036	CbGpPWpGaD
Nimodipine—Nausea—Vincristine—sarcoma	0.000771	0.00296	CcSEcCtD
Nimodipine—Flushing—Epirubicin—sarcoma	0.000769	0.00296	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—sarcoma	0.000769	0.00296	CcSEcCtD
Nimodipine—NR3C2—Gene Expression—FUS—sarcoma	0.000768	0.00357	CbGpPWpGaD
Nimodipine—Hepatitis—Doxorubicin—sarcoma	0.000767	0.00295	CcSEcCtD
Nimodipine—CACNB1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000754	0.00351	CbGpPWpGaD
Nimodipine—Angiopathy—Epirubicin—sarcoma	0.000752	0.00289	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—KDR—sarcoma	0.000752	0.0035	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000751	0.00349	CbGpPWpGaD
Nimodipine—Nausea—Mitoxantrone—sarcoma	0.00075	0.00288	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—sarcoma	0.000749	0.00288	CcSEcCtD
Nimodipine—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—sarcoma	0.000749	0.00348	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PTPRC—sarcoma	0.000747	0.00347	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—PTPRC—sarcoma	0.000746	0.00347	CbGpPWpGaD
Nimodipine—Pruritus—Etoposide—sarcoma	0.000743	0.00286	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—CREB1—sarcoma	0.000743	0.00346	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MYOD1—sarcoma	0.000736	0.00342	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EZR—sarcoma	0.000733	0.00341	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—PLCG1—sarcoma	0.000731	0.0034	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—PLCG1—sarcoma	0.00073	0.00339	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—PTPRC—sarcoma	0.000726	0.00338	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—SRC—sarcoma	0.000724	0.00337	CbGpPWpGaD
Nimodipine—Diarrhoea—Etoposide—sarcoma	0.000719	0.00276	CcSEcCtD
Nimodipine—CYP3A4—liver—sarcoma	0.000717	0.00278	CbGeAlD
Nimodipine—Cardiac disorder—Doxorubicin—sarcoma	0.000712	0.00274	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—sarcoma	0.000712	0.00274	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—PLCG1—sarcoma	0.000711	0.00331	CbGpPWpGaD
Nimodipine—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—sarcoma	0.000709	0.0033	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—KRAS—sarcoma	0.000699	0.00325	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—NRAS—sarcoma	0.000697	0.00324	CbGpPWpGaD
Nimodipine—Angiopathy—Doxorubicin—sarcoma	0.000696	0.00267	CcSEcCtD
Nimodipine—Dizziness—Etoposide—sarcoma	0.000695	0.00267	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—sarcoma	0.000694	0.00267	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—sarcoma	0.000693	0.00266	CcSEcCtD
Nimodipine—AHR—Integrated Breast Cancer Pathway—MYC—sarcoma	0.000691	0.00321	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—SRC—sarcoma	0.000686	0.00319	CbGpPWpGaD
Nimodipine—CACNB3—Myometrial Relaxation and Contraction Pathways—JUN—sarcoma	0.000684	0.00318	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—JUN—sarcoma	0.000683	0.00318	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000675	0.00314	CbGpPWpGaD
Nimodipine—Vomiting—Etoposide—sarcoma	0.000668	0.00257	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—sarcoma	0.000667	0.00256	CcSEcCtD
Nimodipine—Rash—Etoposide—sarcoma	0.000663	0.00255	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—sarcoma	0.000662	0.00254	CcSEcCtD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—NRAS—sarcoma	0.00066	0.00307	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—CREB1—sarcoma	0.000659	0.00307	CbGpPWpGaD
Nimodipine—Headache—Etoposide—sarcoma	0.000658	0.00253	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—FOXO1—sarcoma	0.000649	0.00302	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EZR—sarcoma	0.000644	0.003	CbGpPWpGaD
Nimodipine—Muscle spasms—Doxorubicin—sarcoma	0.000642	0.00247	CcSEcCtD
Nimodipine—CACNB3—Transmission across Chemical Synapses—MDM2—sarcoma	0.000641	0.00298	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—PTPRC—sarcoma	0.000639	0.00297	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000638	0.00297	CbGpPWpGaD
Nimodipine—Palpitations—Epirubicin—sarcoma	0.000638	0.00245	CcSEcCtD
Nimodipine—CACNB2—Developmental Biology—MYOD1—sarcoma	0.000631	0.00294	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—PLCG1—sarcoma	0.000626	0.00291	CbGpPWpGaD
Nimodipine—Nausea—Etoposide—sarcoma	0.000624	0.0024	CcSEcCtD
Nimodipine—CACNB1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000624	0.0029	CbGpPWpGaD
Nimodipine—Hypertension—Epirubicin—sarcoma	0.000623	0.00239	CcSEcCtD
Nimodipine—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—sarcoma	0.000623	0.0029	CbGpPWpGaD
Nimodipine—Anaemia—Doxorubicin—sarcoma	0.000617	0.00237	CcSEcCtD
Nimodipine—CACNB4—Neuronal System—MDM2—sarcoma	0.000615	0.00286	CbGpPWpGaD
Nimodipine—Myalgia—Epirubicin—sarcoma	0.000614	0.00236	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—MMP2—sarcoma	0.000614	0.00286	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—PTPRC—sarcoma	0.000605	0.00282	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—SRC—sarcoma	0.000603	0.0028	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KDR—sarcoma	0.000601	0.0028	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—KRAS—sarcoma	0.0006	0.00279	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MYOD1—sarcoma	0.000598	0.00278	CbGpPWpGaD
Nimodipine—CACNA1S—NCAM signaling for neurite out-growth—HRAS—sarcoma	0.000594	0.00277	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—CREB1—sarcoma	0.000594	0.00276	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—PLCG1—sarcoma	0.000592	0.00276	CbGpPWpGaD
Nimodipine—Palpitations—Doxorubicin—sarcoma	0.00059	0.00227	CcSEcCtD
Nimodipine—Oedema—Epirubicin—sarcoma	0.000589	0.00226	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—KDR—sarcoma	0.000585	0.00272	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—NRAS—sarcoma	0.00058	0.0027	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—CREB1—sarcoma	0.000578	0.00269	CbGpPWpGaD
Nimodipine—Nervous system disorder—Epirubicin—sarcoma	0.000578	0.00222	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—sarcoma	0.000577	0.00222	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—sarcoma	0.000577	0.00222	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—sarcoma	0.000575	0.00221	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—sarcoma	0.000569	0.00219	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—sarcoma	0.000569	0.00218	CcSEcCtD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—KRAS—sarcoma	0.000568	0.00264	CbGpPWpGaD
Nimodipine—AHR—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000567	0.00264	CbGpPWpGaD
Nimodipine—CACNA1S—Alzheimers Disease—TP53—sarcoma	0.000551	0.00257	CbGpPWpGaD
Nimodipine—Hypotension—Epirubicin—sarcoma	0.00055	0.00211	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—sarcoma	0.000545	0.00209	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000537	0.00206	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—KDR—sarcoma	0.000537	0.0025	CbGpPWpGaD
Nimodipine—Nervous system disorder—Doxorubicin—sarcoma	0.000534	0.00205	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—sarcoma	0.000534	0.00205	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—PTPRC—sarcoma	0.000532	0.00248	CbGpPWpGaD
Nimodipine—Tachycardia—Doxorubicin—sarcoma	0.000532	0.00204	CcSEcCtD
Nimodipine—CACNA1C—Axon guidance—PTPRC—sarcoma	0.000532	0.00247	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—CREB1—sarcoma	0.000527	0.00245	CbGpPWpGaD
Nimodipine—Hyperhidrosis—Doxorubicin—sarcoma	0.000527	0.00202	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—sarcoma	0.000525	0.00202	CcSEcCtD
Nimodipine—CACNA1C—Developmental Biology—MYOD1—sarcoma	0.000525	0.00244	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PLCG1—sarcoma	0.000521	0.00242	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—PLCG1—sarcoma	0.000521	0.00242	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—FOXO1—sarcoma	0.000519	0.00241	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—CREB1—sarcoma	0.000513	0.00239	CbGpPWpGaD
Nimodipine—CACNB2—NCAM signaling for neurite out-growth—HRAS—sarcoma	0.00051	0.00237	CbGpPWpGaD
Nimodipine—Hypotension—Doxorubicin—sarcoma	0.000509	0.00196	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000509	0.00195	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—FOXO1—sarcoma	0.000504	0.00235	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—KRAS—sarcoma	0.000499	0.00232	CbGpPWpGaD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000497	0.00191	CcSEcCtD
Nimodipine—CACNB3—Neuronal System—MDM2—sarcoma	0.000491	0.00229	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—MMP2—sarcoma	0.000491	0.00228	CbGpPWpGaD
Nimodipine—Dyspnoea—Doxorubicin—sarcoma	0.000486	0.00187	CcSEcCtD
Nimodipine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000484	0.00225	CbGpPWpGaD
Nimodipine—CACNA1D—NCAM signaling for neurite out-growth—HRAS—sarcoma	0.000483	0.00225	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—MDM2—sarcoma	0.000478	0.00222	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—MMP2—sarcoma	0.000477	0.00222	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000474	0.0022	CbGpPWpGaD
Nimodipine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000471	0.00181	CcSEcCtD
Nimodipine—CACNB4—Developmental Biology—CREB1—sarcoma	0.00047	0.00219	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PTPRC—sarcoma	0.000456	0.00212	CbGpPWpGaD
Nimodipine—AHR—Circadian rythm related genes—TP53—sarcoma	0.000451	0.0021	CbGpPWpGaD
Nimodipine—CACNA1D—Alzheimers Disease—TP53—sarcoma	0.000448	0.00208	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PLCG1—sarcoma	0.000446	0.00208	CbGpPWpGaD
Nimodipine—CACNB4—Transmission across Chemical Synapses—HRAS—sarcoma	0.00044	0.00205	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—MMP2—sarcoma	0.000438	0.00204	CbGpPWpGaD
Nimodipine—Hypersensitivity—Epirubicin—sarcoma	0.000434	0.00167	CcSEcCtD
Nimodipine—CACNA1D—Developmental Biology—PTPRC—sarcoma	0.000432	0.00201	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KDR—sarcoma	0.000429	0.002	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KDR—sarcoma	0.000428	0.00199	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—SRC—sarcoma	0.000425	0.00198	CbGpPWpGaD
Nimodipine—CACNA1C—NCAM signaling for neurite out-growth—HRAS—sarcoma	0.000424	0.00197	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PLCG1—sarcoma	0.000423	0.00197	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KDR—sarcoma	0.000417	0.00194	CbGpPWpGaD
Nimodipine—Pruritus—Epirubicin—sarcoma	0.000417	0.0016	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—VEGFA—sarcoma	0.000414	0.00193	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—NRAS—sarcoma	0.000409	0.0019	CbGpPWpGaD
Nimodipine—Diarrhoea—Epirubicin—sarcoma	0.000403	0.00155	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—sarcoma	0.000402	0.00154	CcSEcCtD
Nimodipine—CACNA1C—Alzheimers Disease—TP53—sarcoma	0.000393	0.00183	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000392	0.00182	CbGpPWpGaD
Nimodipine—Dizziness—Epirubicin—sarcoma	0.00039	0.0015	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—sarcoma	0.000386	0.00148	CcSEcCtD
Nimodipine—CACNA1C—Developmental Biology—PTPRC—sarcoma	0.00038	0.00177	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CREB1—sarcoma	0.000376	0.00175	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—CREB1—sarcoma	0.000376	0.00175	CbGpPWpGaD
Nimodipine—Vomiting—Epirubicin—sarcoma	0.000375	0.00144	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—sarcoma	0.000373	0.00143	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—EGFR—sarcoma	0.000373	0.00173	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PLCG1—sarcoma	0.000371	0.00173	CbGpPWpGaD
Nimodipine—Rash—Epirubicin—sarcoma	0.000371	0.00143	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—sarcoma	0.000371	0.00143	CcSEcCtD
Nimodipine—CACNA1S—Developmental Biology—FOXO1—sarcoma	0.000369	0.00172	CbGpPWpGaD
Nimodipine—Headache—Epirubicin—sarcoma	0.000369	0.00142	CcSEcCtD
Nimodipine—CACNB2—Axon guidance—KDR—sarcoma	0.000367	0.00171	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CREB1—sarcoma	0.000366	0.0017	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—CREB1—sarcoma	0.000363	0.00169	CbGpPWpGaD
Nimodipine—Dizziness—Doxorubicin—sarcoma	0.00036	0.00138	CcSEcCtD
Nimodipine—CACNB4—Axon guidance—KRAS—sarcoma	0.000352	0.00164	CbGpPWpGaD
Nimodipine—CACNB3—Transmission across Chemical Synapses—HRAS—sarcoma	0.000352	0.00164	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP2—sarcoma	0.00035	0.00163	CbGpPWpGaD
Nimodipine—Nausea—Epirubicin—sarcoma	0.00035	0.00134	CcSEcCtD
Nimodipine—CACNA1S—Axon guidance—MMP2—sarcoma	0.00035	0.00163	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KDR—sarcoma	0.000348	0.00162	CbGpPWpGaD
Nimodipine—Vomiting—Doxorubicin—sarcoma	0.000347	0.00133	CcSEcCtD
Nimodipine—Rash—Doxorubicin—sarcoma	0.000344	0.00132	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—sarcoma	0.000343	0.00132	CcSEcCtD
Nimodipine—CACNB3—Metabolism—ENO2—sarcoma	0.000343	0.00159	CbGpPWpGaD
Nimodipine—CACNB1—Transmission across Chemical Synapses—HRAS—sarcoma	0.000342	0.00159	CbGpPWpGaD
Nimodipine—Headache—Doxorubicin—sarcoma	0.000341	0.00131	CcSEcCtD
Nimodipine—CACNB1—Developmental Biology—MMP2—sarcoma	0.000341	0.00158	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—HBA1—sarcoma	0.00034	0.00158	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—SRC—sarcoma	0.00034	0.00158	CbGpPWpGaD
Nimodipine—CACNB4—Neuronal System—HRAS—sarcoma	0.000337	0.00157	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—CTNNB1—sarcoma	0.000336	0.00156	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—VEGFA—sarcoma	0.000331	0.00154	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—SRC—sarcoma	0.000331	0.00154	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—NRAS—sarcoma	0.000327	0.00152	CbGpPWpGaD
Nimodipine—Nausea—Doxorubicin—sarcoma	0.000324	0.00124	CcSEcCtD
Nimodipine—CACNB1—Axon guidance—VEGFA—sarcoma	0.000322	0.0015	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—CREB1—sarcoma	0.000322	0.0015	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—NRAS—sarcoma	0.000318	0.00148	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—FOXO1—sarcoma	0.000317	0.00147	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KDR—sarcoma	0.000306	0.00142	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KDR—sarcoma	0.000306	0.00142	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—CREB1—sarcoma	0.000305	0.00142	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—SRC—sarcoma	0.000303	0.00141	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—MDM2—sarcoma	0.0003	0.0014	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—FOXO1—sarcoma	0.0003	0.0014	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP2—sarcoma	0.0003	0.00139	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—HRAS—sarcoma	0.000299	0.00139	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—sarcoma	0.000298	0.00139	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—VEGFA—sarcoma	0.000296	0.00138	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—NRAS—sarcoma	0.000292	0.00136	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PLCG1—sarcoma	0.000291	0.00135	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—sarcoma	0.00029	0.00135	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP2—sarcoma	0.000284	0.00132	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KRAS—sarcoma	0.000282	0.00131	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—sarcoma	0.000274	0.00127	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—sarcoma	0.00027	0.00125	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—CTNNB1—sarcoma	0.000268	0.00125	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CREB1—sarcoma	0.000268	0.00125	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—CREB1—sarcoma	0.000268	0.00125	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—sarcoma	0.000266	0.00124	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—FOXO1—sarcoma	0.000264	0.00123	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—sarcoma	0.000262	0.00122	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KDR—sarcoma	0.000262	0.00122	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—CTNNB1—sarcoma	0.000261	0.00121	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—sarcoma	0.000251	0.00117	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP2—sarcoma	0.000249	0.00116	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP2—sarcoma	0.000249	0.00116	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KDR—sarcoma	0.000248	0.00115	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—SRC—sarcoma	0.000243	0.00113	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—SRC—sarcoma	0.000242	0.00113	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—sarcoma	0.000239	0.00111	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—VEGFA—sarcoma	0.000236	0.0011	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SRC—sarcoma	0.000236	0.0011	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—VEGFA—sarcoma	0.000236	0.0011	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—NRAS—sarcoma	0.000233	0.00109	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—NRAS—sarcoma	0.000233	0.00108	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—sarcoma	0.000233	0.00108	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—VEGFA—sarcoma	0.00023	0.00107	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CREB1—sarcoma	0.00023	0.00107	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—NRAS—sarcoma	0.000227	0.00106	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KDR—sarcoma	0.000218	0.00101	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CREB1—sarcoma	0.000218	0.00101	CbGpPWpGaD
Nimodipine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000217	0.00101	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—sarcoma	0.000215	0.001	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP2—sarcoma	0.000214	0.000995	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—sarcoma	0.000214	0.000994	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—sarcoma	0.000213	0.000989	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—sarcoma	0.000212	0.000988	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO2—sarcoma	0.000209	0.000974	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HBA1—sarcoma	0.000208	0.000967	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—SRC—sarcoma	0.000208	0.000966	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—sarcoma	0.000207	0.000965	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—sarcoma	0.000207	0.000962	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP2—sarcoma	0.000203	0.000942	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—VEGFA—sarcoma	0.000202	0.000941	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—sarcoma	0.000201	0.000935	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—sarcoma	0.000201	0.000933	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—NRAS—sarcoma	0.0002	0.00093	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO2—sarcoma	0.000198	0.000922	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HBA1—sarcoma	0.000197	0.000916	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—SRC—sarcoma	0.000197	0.000915	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—sarcoma	0.000195	0.000909	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—VEGFA—sarcoma	0.000192	0.000891	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CTNNB1—sarcoma	0.000191	0.00089	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CREB1—sarcoma	0.000191	0.000889	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—NRAS—sarcoma	0.000189	0.00088	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—sarcoma	0.000182	0.000847	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP2—sarcoma	0.000178	0.000828	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PLCG1—sarcoma	0.000178	0.000826	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO2—sarcoma	0.000174	0.00081	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HBA1—sarcoma	0.000173	0.000805	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SRC—sarcoma	0.000173	0.000804	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—SRC—sarcoma	0.000173	0.000804	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—sarcoma	0.000172	0.000802	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—sarcoma	0.000172	0.0008	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—sarcoma	0.000171	0.000794	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—sarcoma	0.00017	0.000793	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—VEGFA—sarcoma	0.000168	0.000783	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—VEGFA—sarcoma	0.000168	0.000783	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PLCG1—sarcoma	0.000168	0.000782	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—NRAS—sarcoma	0.000166	0.000774	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—NRAS—sarcoma	0.000166	0.000773	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—sarcoma	0.000166	0.000773	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—sarcoma	0.000165	0.000766	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CTNNB1—sarcoma	0.000164	0.000763	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—sarcoma	0.000163	0.000758	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CTNNB1—sarcoma	0.000155	0.000722	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—sarcoma	0.000152	0.000705	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—sarcoma	0.000151	0.000705	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SRC—sarcoma	0.000148	0.00069	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PLCG1—sarcoma	0.000148	0.000687	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—sarcoma	0.000146	0.00068	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—VEGFA—sarcoma	0.000144	0.000672	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—sarcoma	0.000143	0.000666	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—sarcoma	0.000143	0.000666	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—NRAS—sarcoma	0.000143	0.000663	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SRC—sarcoma	0.00014	0.000653	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—sarcoma	0.000138	0.000644	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—VEGFA—sarcoma	0.000137	0.000636	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CTNNB1—sarcoma	0.000136	0.000635	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—NRAS—sarcoma	0.000135	0.000628	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—sarcoma	0.00013	0.000604	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—sarcoma	0.000123	0.000574	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—sarcoma	0.000123	0.000572	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—sarcoma	0.000123	0.000571	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—sarcoma	0.000122	0.000566	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—sarcoma	0.000122	0.000566	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—VEGFA—sarcoma	0.00012	0.000559	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NRAS—sarcoma	0.000119	0.000552	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—sarcoma	0.000116	0.000541	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—sarcoma	0.000108	0.000503	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—sarcoma	0.000104	0.000485	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—sarcoma	0.000102	0.000475	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—sarcoma	9.98e-05	0.000464	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—sarcoma	9.88e-05	0.00046	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—sarcoma	8.68e-05	0.000404	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO2—sarcoma	7.71e-05	0.000359	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HBA1—sarcoma	7.66e-05	0.000356	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PLCG1—sarcoma	6.54e-05	0.000304	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO2—sarcoma	3.58e-05	0.000167	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HBA1—sarcoma	3.56e-05	0.000166	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PLCG1—sarcoma	3.04e-05	0.000141	CbGpPWpGaD
